Published: September 03, 2022 18:42:18 | Updated: September 10, 2022 16:46:07
Britain's medicines regulator on Saturday approved Pfizer/BioNTech's updated bivalent Covid-19 booster shot for people aged 12 years and older, Reuters.
The Medicines and Healthcare products Regulatory Agency said the decision was based on data from a clinical trial that showed a booster dose with the bivalent Pfizer/BioNTech vaccine triggers a strong immune response against both the omicron and the original strain.
Moderna to make milestone payments to US for Covid-19 vaccine
Bird flu situation 'worrying', WHO working with Cambodia
A woman dies every two minutes due to pregnancy or childbirth: UN report
Oral dose of azithromycin at normal birth can reduce 33pc maternal sepsis and deaths: Study
Can topical treatment alone fix acne scars?
Vitamin A-plus campaign for 22.0 million children held
Why the success of making an artificial heart remains elusive?
No specific research on zinc level in rice
© 2024 - All Rights with The Financial Express
